Trials / Completed
CompletedNCT05044156
Investigation of the Relationship Between Salivary Histatine-5 Level and Vaginal Candidiasis in Women
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 90 (actual)
- Sponsor
- Usak State Hospital · Academic / Other
- Sex
- Female
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The low Histatine-5 (HST-5) level of the saliva can lead to vaginal candidiasis. Because HST-5 level in the saliva can effect vaginal Ph, flora and local defence mechanisms. Histatine-5 is secreted in the parotis and submandibular glands. İt riches histidine amino ascid and have antifungal activity. Salivary proteins and their plasma levels were found as similar in the literature.
Detailed description
Women with regularly menstrual cycle will enroll in the study than will separate two groups: Study group: women with vaginal candidiasis ( diagnosed by clinic and lab.) Control group: women ( not have any vaginal infections candida and others) Saliva samples will be taken from two groups than HST-5 level will be analyzed. Finally HST-5 levels of the two groups will be compared . Women with diabetes, immun deficiency, pregnancy, virgin, menopausal period , premature ovarian failure will be excluded.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | salivary sample | salivary sample |
Timeline
- Start date
- 2021-10-21
- Primary completion
- 2022-03-06
- Completion
- 2022-03-06
- First posted
- 2021-09-14
- Last updated
- 2022-03-08
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT05044156. Inclusion in this directory is not an endorsement.